Mingke Pharmaceutical: Termination of Stock Issuance to Specific Parties

Mingke Pharmaceutical announced in the evening that the company convened the 22nd meeting of the second board of directors on November 15, 2025, and approved the resolution on "Terminating the Issuance of Stocks to Specific Entities". The company had originally planned to issue 164 million shares to Nanjing Haijing Pharmaceutical Co., Ltd. to raise 1.033 billion yuan. Due to the continuous opposition from the major shareholder Genie Pharma to the company's advancement of the issuance plan, and significant disagreements between Genie Pharma, other shareholders, and the company's management, the company decided to terminate the issuance of stocks to specific entities.